Inactivation of Btk by insertion of lacZ reveals defects in B cell development only past the pre-B cell stage - PubMed (original) (raw)

. 1996 Sep 16;15(18):4862-72.

Affiliations

• PMID: 8890160
• PMCID: PMC452224

Inactivation of Btk by insertion of lacZ reveals defects in B cell development only past the pre-B cell stage

R W Hendriks et al. EMBO J. 1996.

Abstract

Bruton's tyrosine kinase (Btk) is a cytoplasmic protein kinase that is defective in X-linked agammaglobulinaemia in man and in X-linked immunodeficiency in the mouse. There is controversy regarding the stages of B cell development that are dependent on Btk function. To determine the point in B cell differentiation at which defects in Btk become apparent, we generated a mouse model by inactivating the Btk gene through an in-frame insertion of a lacZ reporter by homologous recombination in embryonic stem cells. The phenomenon of X-chromosome inactivation in Btk+/- heterozygous female mice enabled us to evaluate the competition between B cell progenitors expressing wild-type Btk and those expressing the Btk-/lacZ allele in each successive step of development. Although Btk was already expressed in pro-B cells, the first selective disadvantage only became apparent at the transition from small pre-B cells to immature B cells in the bone marrow. A second differentiation arrest was found during the maturation from IgD(low)IgM(high) to IgD(high)IgM(low) stages in the periphery. Our results show that Btk expression is essential at two distinct differentiation steps, both past the pre-B cell stage.

PubMed Disclaimer

Similar articles

• The Bruton's tyrosine kinase gene is expressed throughout B cell differentiation, from early precursor B cell stages preceding immunoglobulin gene rearrangement up to mature B cell stages.
  de Weers M, Verschuren MC, Kraakman ME, Mensink RG, Schuurman RK, van Dongen JJ, Hendriks RW. de Weers M, et al. Eur J Immunol. 1993 Dec;23(12):3109-14. doi: 10.1002/eji.1830231210. Eur J Immunol. 1993. PMID: 8258324
• Composition of precursor B-cell compartment in bone marrow from patients with X-linked agammaglobulinemia compared with healthy children.
  Noordzij JG, de Bruin-Versteeg S, Comans-Bitter WM, Hartwig NG, Hendriks RW, de Groot R, van Dongen JJ. Noordzij JG, et al. Pediatr Res. 2002 Feb;51(2):159-68. doi: 10.1203/00006450-200202000-00007. Pediatr Res. 2002. PMID: 11809909
• The role of Bruton's tyrosine kinase in B-cell development and function: a genetic perspective.
  Satterthwaite AB, Witte ON. Satterthwaite AB, et al. Immunol Rev. 2000 Jun;175:120-7. Immunol Rev. 2000. PMID: 10933597 Review.
• Bruton's tyrosine kinase: cell biology, sequence conservation, mutation spectrum, siRNA modifications, and expression profiling.
  Lindvall JM, Blomberg KE, Väliaho J, Vargas L, Heinonen JE, Berglöf A, Mohamed AJ, Nore BF, Vihinen M, Smith CI. Lindvall JM, et al. Immunol Rev. 2005 Feb;203:200-15. doi: 10.1111/j.0105-2896.2005.00225.x. Immunol Rev. 2005. PMID: 15661031 Review.

Cited by

• Effective, safe, and sustained correction of murine XLA using a UCOE-BTK promoter-based lentiviral vector.
  Seymour BJ, Singh S, Certo HM, Sommer K, Sather BD, Khim S, Clough C, Hale M, Pangallo J, Ryu BY, Khan IF, Adair JE, Rawlings DJ. Seymour BJ, et al. Mol Ther Methods Clin Dev. 2021 Jan 20;20:635-651. doi: 10.1016/j.omtm.2021.01.007. eCollection 2021 Mar 12. Mol Ther Methods Clin Dev. 2021. PMID: 33718514 Free PMC article.
• Bruton's tyrosine kinase mediated signaling enhances leukemogenesis in a mouse model for chronic lymphocytic leukemia.
  Kil LP, de Bruijn MJ, van Hulst JA, Langerak AW, Yuvaraj S, Hendriks RW. Kil LP, et al. Am J Blood Res. 2013;3(1):71-83. Epub 2013 Jan 17. Am J Blood Res. 2013. PMID: 23359016 Free PMC article.
• Bruton's Tyrosine Kinase Deficiency Ameliorates Antimicrobial Host Defense during Peritonitis Induced by Pathogenic Escherichia coli.
  Liu Z, van 't Veer C, Hendriks RW, Roelofs JJTH, van der Poll T, de Vos AF. Liu Z, et al. Infect Immun. 2022 Jun 16;90(6):e0067421. doi: 10.1128/iai.00674-21. Epub 2022 May 19. Infect Immun. 2022. PMID: 35587199 Free PMC article.
• Role of Bruton's tyrosine kinase in B cells and malignancies.
  Pal Singh S, Dammeijer F, Hendriks RW. Pal Singh S, et al. Mol Cancer. 2018 Feb 19;17(1):57. doi: 10.1186/s12943-018-0779-z. Mol Cancer. 2018. PMID: 29455639 Free PMC article. Review.
• Btk dosage determines sensitivity to B cell antigen receptor cross-linking.
  Satterthwaite AB, Cheroutre H, Khan WN, Sideras P, Witte ON. Satterthwaite AB, et al. Proc Natl Acad Sci U S A. 1997 Nov 25;94(24):13152-7. doi: 10.1073/pnas.94.24.13152. Proc Natl Acad Sci U S A. 1997. PMID: 9371815 Free PMC article.

References

1. 1. J Exp Med. 1993 Sep 1;178(3):951-60 - PubMed
2. 1. Pediatrics. 1952 Jun;9(6):722-8 - PubMed
3. 1. Int Immunol. 1993 Sep;5(9):1093-8 - PubMed
4. 1. J Immunol. 1994 Jan 15;152(2):557-65 - PubMed
5. 1. Leukemia. 1994 Apr;8(4):574-7 - PubMed

Publication types

MeSH terms

Substances

LinkOut - more resources

• Full Text Sources

  • Europe PubMed Central
  • PubMed Central
  • Wiley

• Other Literature Sources

  • The Lens - Patent Citations Database

• Molecular Biology Databases

  • Mouse Genome Informatics (MGI)

• Miscellaneous

  • NCI CPTAC Assay Portal